Skip to main content

Research Repository

Advanced Search

Development of novel 9-O-substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents

Chen, Jichao; Duan, Yiping; Yu, Xiaoxuan; Zhong, Jiarou; Bai, Jing; Li, Nian Guang; Zhu, Zheying; Xu, Jinyi

Development of novel 9-O-substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents Thumbnail


Authors

Jichao Chen

Yiping Duan

Xiaoxuan Yu

Jiarou Zhong

Jing Bai

Nian Guang Li

ZHEYING ZHU Zheying.Zhu@nottingham.ac.uk
Associate Professor in International Pharmacy and Traditional Medicines

Jinyi Xu



Abstract

A series of novel 9-O-substituted-13-octylberberine derivatives were designed, synthesised and evaluated for their anti-hepatocellular carcinoma (HCC) activities. Compound 6k showed the strongest activity against three human hepatoma cells including HepG2, Sk-Hep-1 and Huh-7 cells with IC50 values from 0.62 to 1.69 μM, which were much superior to berberine (IC50 >50 μM). More importantly, 6k exhibited lower cytotoxicity against normal hepatocytes L-02 with good lipid-water partition properties. The mechanism studies revealed that 6k caused G2/M phase arrest of the cell cycle, stabilised G-quadruplex DNA, and induced apoptosis via a mitochondrial apoptotic pathway. Finally, the invivo anti-HCC activity of 6k was validated in the H22 liver cancer xenograft mouse model. Collectively, the current study would provide a new insight into the discovery of novel, safe and effective anti-HCC agents.

Citation

Chen, J., Duan, Y., Yu, X., Zhong, J., Bai, J., Li, N. G., …Xu, J. (2022). Development of novel 9-O-substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 2423-2433. https://doi.org/10.1080/14756366.2022.2118268

Journal Article Type Article
Acceptance Date Aug 21, 2022
Online Publication Date Sep 6, 2022
Publication Date Dec 1, 2022
Deposit Date Sep 10, 2022
Publicly Available Date Sep 13, 2022
Journal Journal of enzyme inhibition and medicinal chemistry
Print ISSN 1475-6366
Electronic ISSN 1475-6374
Publisher Informa UK Limited
Peer Reviewed Peer Reviewed
Volume 37
Issue 1
Pages 2423-2433
DOI https://doi.org/10.1080/14756366.2022.2118268
Keywords Drug Discovery; Pharmacology; General Medicine
Public URL https://nottingham-repository.worktribe.com/output/10920295
Publisher URL https://www.tandfonline.com/doi/full/10.1080/14756366.2022.2118268

Files




You might also like



Downloadable Citations